Table III.
Univariate analysis of overall survival in patients with lung adenocarcinoma.
| Characteristics | HR (95% CI)a | P-value |
|---|---|---|
| Age | 0.694 (0.415, 1.163) | 0.165 |
| Gender | 0.550 (0.322, 0.938) | 0.028 |
| TNM stage | 1.733 (1.259, 2.386) | 0.001 |
| Node status | 3.552 (1.938, 6.510) | <0.001 |
| Tumor size | 1.430 (0.829, 2.468) | 0.199 |
| Differentiation | 0.692 (0.481, 0.996) | 0.048 |
| 14-3-3ζ expression | 0.754 (0.575, 0.990) | 0.042 |
| E-cadherin expression | 0.729 (0.546, 0.974) | 0.032 |
| Chemotherapy | 0.651 (0.388, 1.091) | 0.103 |
a
Variables were adopted for their prognostic significance (P<0.05) in univariate analysis using forward, stepwise selection (forward likelihood ratio). CI, confidence interval; HR, hazard ratio; OS, overall survival.